Soluble Fas levels in sera of bone marrow transplantation recipients are increased during acute graft-versus-host disease but not during infections.
Graft-versus-host disease (GVHD) and infections are two major complications of allogeneic bone marrow transplantation (BMT). In the course of GVHD, one of the pathways that activated cytotoxic T cells use to execute their killing mechanisms is the Fas/Fas ligand pathway. This killing mechanism might be accompanied by the release of soluble Fas (sFas) in the circulation. To examine the association of serum sFas levels and post-BMT complications, we have analyzed sFas levels in sera of bone marrow recipients with and without GVHD. Postallogeneic BMT sFas levels were significantly increased during clinically relevant acute GVHD (aGVHD; P = .002). However, during infections sFas levels tended to decrease (P = .088). Yet, the simultaneous occurrence of GVHD and infections resulted in extreme high sFas levels. These results suggested that sFas release may be correlated with the amount of tissue damage, because aGVHD induces more damage than infections. The presence of significantly increased sFas levels during aGVHD provides new insights into the GVHD pathogenesis.
Liem
L M
LM
Department of Immunohematology and Blood Bank, Leiden University Medical Center, Leiden, The Netherlands.
van Lopik
T
T
van Nieuwenhuijze
A E
AE
van Houwelingen
H C
HC
Aarden
L
L
Goulmy
E
E
D000328:Adult; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D003141:Communicable Diseases / Q000097:blood* / Q000209:etiology; D005260:Female; D006086:Graft vs Host Disease / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D014184:Transplantation, Homologous; D019014:fas Receptor / Q000097:blood*
D019014:fas Receptor